Raccourcissement de la durée de traitement de la tuberculose

Moxifloxacin or rifapentine-based short course regimens in association with first line drugs for drug-sensitive tuberculosis results in high relapse rates and should nowadays not be preferred to the standard 6 months regimen. Further trials that explore short course of new antituberculosis drugs associations are needed for either drug-sensitive or resistant tuberculosis.